RA Capital Nexus Fund IV, L.P.
CIK 2053586
Transactions on file
9
Open-market buys
6
Win rate (buys)
83%
6 scored
Avg % since filing (buys)
+14.1%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 53,407 | $1.33M | +0.6% | open → |
| 2026-05-06 | 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 14,611 | $347.3K | +5.1% | open → |
| 2026-05-06 | 2026-05-05 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 10,268 | $256.7K | -0.1% | open → |
| 2026-05-06 | 2026-05-05 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 87,143 | $2.14M | +1.6% | open → |
| 2026-05-06 | 2026-05-04 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 133,750 | $2.41M | +38.8% | open → |
| 2026-05-06 | 2026-05-04 | COAG Hemab Therapeutics Holdings, Inc. | Director | Buy | 2,541,250 | $45.74M | +38.8% | open → |
| 2026-05-06 | 2026-05-04 | COAG Hemab Therapeutics Holdings, Inc. | Director | C | 221,188 | $0.00 | — | open → |
| 2026-05-06 | 2026-05-04 | COAG Hemab Therapeutics Holdings, Inc. | Director | C | 1,009,052 | $0.00 | — | open → |
| 2026-05-06 | 2026-05-04 | COAG Hemab Therapeutics Holdings, Inc. | Director | C | 3,607,846 | $0.00 | — | open → |
